Hepatitis B virus is inhibited by RNA interference in cell culture and in mice

Antiviral Research

Volumn 73, Issue 1, 2007, Pages 24-30

  Ying, Ruo Su ^a   Zhu, Cai ^a   Fan, Xue Gong ^a   Li, Ning ^a   Tian, Xue Fei ^a   Liu, Hong Bo ^a   Zhang, Bao Xin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Animal model; HBV; HepG2.2.15; Hydrodynamics; RNAi

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; MESSENGER RNA; SHORT HAIRPIN RNA; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG DOSE COMPARISON; FLUOROMETRY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; VIRUS REPLICATION;

ANIMALS; CELL LINE, TUMOR; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; HUMANS; MICE; MICE, INBRED BALB C; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA, VIRAL; TRANSFECTION; VIRUS REPLICATION;

ANIMALIA; HEPATITIS B VIRUS; MUS;

EID: 33846124558     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2006.05.022     Document Type: Article

References (29)

1. Bernstein E., Caudy A.A., Hammond S.M., et al. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409 (2001) 363-366
2. Carmona S., Ely A., Crowther C., et al. Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs. Mol. Ther. 13 (2006) 411-421
3. Chi J.T., Chang H.Y., Wang N.N., et al. Genomewide view of gene silencing by small interfering RNAs. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 6343-6346
4. Dienstag J.L., Cianciara J., Karayalcin S., et al. Durability of serologic response after lamivudine treatment of chronic hepatitis B. Hepatology 37 (2003) 748-755
5. Elbashir S.M., Lendeckel W., and Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes 15 (2001) 188-200
6. Giladi H., Ketzinel-Gilad M., Rivkin L., et al. Small interfering RNA inhibits hepatitis B virus replication in mice. Mol. Ther. 8 (2003) 769-776
7. Hammond S.M., Bernstein E., Beach D., et al. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404 (2000) 293-296
8. Hammond S.M., Caudy A.A., and Hannon G.J. Post-transcriptional gene silencing by double-stranded RNA. Nat. Rev. Genet. 2 (2001) 110-119
9. Hannon G.J. RNA interference. Nature 418 (2000) 244-251
10. Lai C.L., Rosmawati M., Lao J., et al. Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection. Gastroenterology 123 (2002) 1831-1838
11. Lee W.M. Hepatitis B virus infection. N. Engl. J. Med. 337 (1997) 1733-1745
12. Li N., Fan X.G., Chen Z.H., et al. Inhibition of the hepatitis B virus replication in vitro by an oligodeoxynucleotide containing cytidine-guanosine motifs. Immunol. Lett. 102 (2005) 60-66
13. Liaw Y.F. Therapy of chronic hepatitis B: current challenges and opportunities. J. Viral. Hepat. 9 (2002) 393-399
14. Lin O.S., and Keeffe E.B. Current treatment strategies for chronic hepatitis B and C. Annu. Rev. Med. 52 (2001) 29-49
15. Liu F., Song Y., and Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6 (1999) 1258-1266
16. Lok A.S. Hepatitis B infection: pathogenesis and management. J. Hepatol. 32 (2000) s89-s97
17. Marcellin P., Chang T.T., Lim S.G., et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen positive chronic hepatitis B. N. Engl. J. Med. 348 (2003) 808-816
18. McCaffrey A.P., Nakai H., Pandey K., et al. Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 21 (2003) 639-644
19. McManus M.T., and Sharp P.A. Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3 (2002) 737-747
20. Peng J., Zhao Y., Mai J., et al. Inhibition of hepatitis B virus replication by various RNAi constructs and their pharmacodynamic properties. J. Gen. Virol. 86 (2005) 3227-3234
21. Sells M.A., Chen M.L., and Acs G. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 1005-1009
22. Shlomai A., and Shaul Y. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 37 (2003) 764-770
23. Song E., Lee S.K., Wang J., et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9 3 (2003) 347-351
24. Tang N., Huang A.L., Zhang B.Q., et al. Construction recombinant eukaryotic expression plasmid containing 1.3-fold-overlength genome of HBV and its expression in HepG2cells. Chin. J. Hepatol. 11 (2003) 464-466
25. Tuschl T. Expanding small RNA interference. Nat. Biotechnol. 20 (2002) 446-448
26. Uprichard S.L., Boyd B., Althage A., et al. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 773-778
27. Yang P.L., Althage A., Chung J., et al. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 13825-13830
28. Yu J.Y., Ruiter S.L.D., and Turner D.L. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 6047-6052
29. Zhang G., Budker V., and Wolff J.A. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 10 (1999) 1735-1737